Literature DB >> 25595557

Quantifying on- and off-target genome editing.

Ayal Hendel1, Eli J Fine2, Gang Bao2, Matthew H Porteus3.   

Abstract

Genome editing with engineered nucleases is a rapidly growing field thanks to transformative technologies that allow researchers to precisely alter genomes for numerous applications including basic research, biotechnology, and human gene therapy. While the ability to make precise and controlled changes at specified sites throughout the genome has grown tremendously in recent years, we still lack a comprehensive and standardized battery of assays for measuring the different genome editing outcomes created at endogenous genomic loci. Here we review the existing assays for quantifying on- and off-target genome editing and describe their utility in advancing the technology. We also highlight unmet assay needs for quantifying on- and off-target genome editing outcomes and discuss their importance for the genome editing field.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRISPR/Cas9; RNA-guided endonucleases; TALENs; ZFNs; gene editing; gene targeting; homologous recombination; nonhomologous end-joining

Mesh:

Substances:

Year:  2015        PMID: 25595557      PMCID: PMC4308725          DOI: 10.1016/j.tibtech.2014.12.001

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  72 in total

1.  Surrogate reporters for enrichment of cells with nuclease-induced mutations.

Authors:  Hyojin Kim; Eunji Um; Sung-Rae Cho; Chorong Jung; Hyongbum Kim; Jin-Soo Kim
Journal:  Nat Methods       Date:  2011-10-09       Impact factor: 28.547

2.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 3.  Repair of strand breaks by homologous recombination.

Authors:  Maria Jasin; Rodney Rothstein
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

4.  Knockout rats generated by embryo microinjection of TALENs.

Authors:  Laurent Tesson; Claire Usal; Séverine Ménoret; Elo Leung; Brett J Niles; Séverine Remy; Yolanda Santiago; Anna I Vincent; Xiangdong Meng; Lei Zhang; Philip D Gregory; Ignacio Anegon; Gregory J Cost
Journal:  Nat Biotechnol       Date:  2011-08-05       Impact factor: 54.908

5.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

6.  An unbiased method for detection of genome-wide off-target effects in cell lines treated with zinc finger nucleases.

Authors:  Cory R Lindsay; David B Roth
Journal:  Methods Mol Biol       Date:  2014

7.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases.

Authors:  Fyodor D Urnov; Jeffrey C Miller; Ya-Li Lee; Christian M Beausejour; Jeremy M Rock; Sheldon Augustus; Andrew C Jamieson; Matthew H Porteus; Philip D Gregory; Michael C Holmes
Journal:  Nature       Date:  2005-04-03       Impact factor: 49.962

8.  Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system.

Authors:  R Torres; M C Martin; A Garcia; Juan C Cigudosa; J C Ramirez; S Rodriguez-Perales
Journal:  Nat Commun       Date:  2014-06-03       Impact factor: 14.919

9.  Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients.

Authors:  David G Ousterout; Pablo Perez-Pinera; Pratiksha I Thakore; Ami M Kabadi; Matthew T Brown; Xiaoxia Qin; Olivier Fedrigo; Vincent Mouly; Jacques P Tremblay; Charles A Gersbach
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

10.  megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering.

Authors:  Sandrine Boissel; Jordan Jarjour; Alexander Astrakhan; Andrew Adey; Agnès Gouble; Philippe Duchateau; Jay Shendure; Barry L Stoddard; Michael T Certo; David Baker; Andrew M Scharenberg
Journal:  Nucleic Acids Res       Date:  2013-11-26       Impact factor: 16.971

View more
  56 in total

1.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

Review 2.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

Review 3.  To CRISPR and beyond: the evolution of genome editing in stem cells.

Authors:  Kuang-Yui Chen; Paul S Knoepfler
Journal:  Regen Med       Date:  2016-12-01       Impact factor: 3.806

Review 4.  Technical considerations for the use of CRISPR/Cas9 in hematology research.

Authors:  Michael C Gundry; Daniel P Dever; David Yudovich; Daniel E Bauer; Simon Haas; Adam C Wilkinson; Sofie Singbrant
Journal:  Exp Hematol       Date:  2017-07-27       Impact factor: 3.084

Review 5.  DNA-free genome editing methods for targeted crop improvement.

Authors:  Chidananda Nagamangala Kanchiswamy
Journal:  Plant Cell Rep       Date:  2016-04-21       Impact factor: 4.570

6.  Multicellular Systems to Translate Somatic Cell Genome Editors to Humans.

Authors:  Victor Hernandez-Gordillo; Thomas Caleb Casolaro; Mo R Ebrahimkhani; Samira Kiani
Journal:  Curr Opin Biomed Eng       Date:  2020-10-10

7.  Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.

Authors:  Annalisa Lattanzi; Vasco Meneghini; Giulia Pavani; Fatima Amor; Sophie Ramadier; Tristan Felix; Chiara Antoniani; Cecile Masson; Olivier Alibeu; Ciaran Lee; Matthew H Porteus; Gang Bao; Mario Amendola; Fulvio Mavilio; Annarita Miccio
Journal:  Mol Ther       Date:  2018-10-17       Impact factor: 11.454

8.  Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.

Authors:  Xiaohong Chen; Yuxuan Chen; Huhu Xin; Tao Wan; Yuan Ping
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-15       Impact factor: 11.205

Review 9.  Genome Editing: A New Horizon for Oral and Craniofacial Research.

Authors:  N Yu; J Yang; Y Mishina; W V Giannobile
Journal:  J Dent Res       Date:  2018-10-24       Impact factor: 6.116

Review 10.  Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions.

Authors:  William T Hendriks; Curtis R Warren; Chad A Cowan
Journal:  Cell Stem Cell       Date:  2016-01-07       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.